ES Razvi - Regenerative Medicine, 2011 - Future Medicine ... Conference Scene. Enal S Razvi Sections ... In conclusion, Dr Csete stated that translation of iPS cells into the clinic will in fact take place but will definitely be preceded by the translation of hESCs – in this vein, the field is carefully watching the Geron Corporation (Menlo Park, CA ... All 3 versions
B Brondén, A Eyjolfsson, S Blomquist… - Acta …, 2011 - Wiley Online Library ... Renal dysfunction after cardiac surgery is not unusual, with 1–5% of the patients requiring dialysis. ... Study protocol. A pre-operative blood sample (baseline test) was drawn from a peripheral vein to determine whether any residual iohexol was present in the blood. ... Related articles - All 4 versions
HR Levey, S Rais-Bahrami, L Richstone… - Journal of …, 2011 - liebertonline.com ... R enal transplantation is the best available option for treating patients with end-stage renal disease. ... 1,2,14,22 While the left kidney is generally preferred for LLDN because of greater renal vein length and technical ease of dissection compared with right-sided nephrectomies ... Related articles - All 2 versions
[PDF] from digitaljournals.orgW Angthong - Siriraj Medical Journal, 2011 - thailand.digitaljournals.org Page 1. 18 OriginalArticle R enal cell carcinoma (RCC) represents 85-90% of all malignant ... lesion. - Renal vein or inferior vena cava (IVC) involve- ment was determined by a low-attenuation filling defect within vein. - Adrenal ... Related articles - All 2 versions
MG Nilson… - Journal of the American Chemical Society, 2011 - ACS Publications ... Key steps include an intramolecular [4 + 3] cyclization of a disubstituted furan with a (Z)-2-(trialkylsilyloxy)-2-enal to construct the tetracyclic core and a ... Cortistatins AD1a and JL1c inhibited the proliferation of human umbilical vein endothelial cells (HUVECs) with high selectivity. ...